Lewis, Gavin A. http://orcid.org/0000-0001-6754-836X
Dodd, Susanna
Clayton, Dannii http://orcid.org/0000-0003-3535-3466
Bedson, Emma
Eccleson, Helen
Schelbert, Erik B. http://orcid.org/0000-0003-0356-4437
Naish, Josephine H.
Jimenez, Beatriz Duran
Williams, Simon G.
Cunnington, Colin
Ahmed, Fozia Zahir
Cooper, Anne
Rajavarma Viswesvaraiah,
Russell, Stuart
McDonagh, Theresa
Williamson, Paula R.
Miller, Christopher A. http://orcid.org/0000-0002-5957-7088
Funding for this research was provided by:
DH | National Institute for Health Research (CS-2015-15-003)
Article History
Received: 24 December 2020
Accepted: 25 June 2021
First Online: 12 August 2021
Competing interests
: C.A.M. has previously received research support for other research from Guerbet, has served on an advisory board for Novartis and serves has an advisor for HAYA Therapeutics. None of these relationships are relevant to the content of this paper. The investigational medicinal product was gifted by Roche Products Limited. Immunoassay testing equipment and materials were gifted by Roche Diagnostics International Limited. Roche Products Limited and Roche Diagnostics International Limited had no role in the design and conduct of the study, the collection, management, analysis and interpretation of the data, the preparation or approval of the manuscript, and the decision to submit the manuscript for publication. Roche Products Limited and Roche Diagnostics International Limited conducted a factual accuracy check of this manuscript, but any decisions to incorporate comments were made solely at the discretion of the authors.